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ABSTRACT
Background : Miscarriage is a common problem in pregnancy which can occur during early, mid 
or late pregnancy. Incomplete miscarriage can be treated expectantly, medically or 
surgically. The most preferred method used in UKMMC is using sharp curettage.
Methodology : This study is conducted in the UKMMC from 1st January 2010 to 30th March 2010. 
The purpose of this study is to analyze the cost of treating incomplete miscarriage 
using metal sharp curettage from the provider’s perspective per patient-day.
Result : A total of 17 samples were eligible for analysis from 46 patients who fulfilled the 
inclusion and exclusion criteria. The cost is derived from cost calculation on capital 
and recurrent costs. Results showed that the average cost for treating incomplete 
miscarriage using sharp curettage per day is RM252.56. Recurrent costs contributed 
83.3% of the total treatment with overhead cost was the biggest percentage (51.6%).
Discussion The treatment cost for incomplete miscarriage using sharp curettage is found to be 
higher as compared to medical approach according to literatures. The higher cost of 
surgical approach was mainly attributed to the recurrent cost which is included in 
the calculation.
Conclusion : Effective usage of the operation theatre and all resources should be managed and 
utilized well in order to achieve optimum outcome.
Keywords : Cost Analysis, Provider Cost, Incomplete Miscarriage, Sharp Curettage, Dilatation 
And Curettage (D&C).
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INTRODUCTION
Miscarriage accounts for approximately 
50 000 inpatient admissions in the United 
Kingdom annually. It is common, occurring in 
15–20% of all pregnancies, and can have both 
medical and psychological consequences and 
mostly about 80% occurring in the first 
trimester of pregnancy1. In University 
Kebangsaan Malaysia Medical Centre 
(UKMMC) from January 2010 to Mac 2010 
there are 47 cases were admitted due to 
incomplete miscarriage.
A miscarriage is actually the spontaneous 
or induced loss of an early pregnancy. The 
period of pregnancy prior to fetal viability 
outside of the uterus is considered early 
pregnancy. Most consider early pregnancy to 
end at 20 weeks' gestation or when the fetus 
weighs 500 grams. Chromosomal 
abnormalities in the embryo are the 
commonest cause for miscarriages2 Typically, 
the distribution of miscarriage rates by age 
occurs as follows: younger than 35 years old, 
15% miscarriage rate; 35-39 years old, 20-25% 
miscarriage rate; 40-42 years old, about 35% 
miscarriage rate; and older than 42 years old, 
about 50% miscarriage rate.
Traditionally, the diagnosis and treatment 
of this condition has depended on the patient’s 
symptoms because viability was difficult to 
determine before documentation of audible 
fetal heart tones in the second trimester. Thus, 
the classic diagnostic categories and treatment 
approaches are based on clinical presentation. 
Threatened abortion, with bleeding in the 
presence of a closed cervix, but with unknown 
viability, was treated expectantly. When the 
cervix had dilated, inevitable and incomplete 
spontaneous abortions were treated with 
uterine curettage because these conditions 
indicate non viability of the pregnancy3. 
Surgical evacuation of the uterus for 
management of incomplete abortion also 
called evacuation of retained product of 
conception usually involves vacuum aspiration 
or sharp metal curettage. Vacuum aspiration 
(also called suction curettage, menstrual 
regulation, endometrial aspiration, or mini-
suction) utilises a vacuum source for the 
evacuation of the uterus. It can be performed 
on an outpatient basis with local anesthesia or 
analgesics. Vacuum aspiration can be used 
without electricity with a hand-held vacuum 
syringe (Manual Vacuum Aspiration). It can 
also be performed with an electric or foot-
operated mechanical pump. Sharp metal 
curettage (also called D & C or dilatation and 
curettage) is often performed in an operating 
room under general anesthesia. In this method, 
a metal curette is used to evacuate the contents 
of the uterus. Sharp curettage is mostly 
performed without dilatation of the cervix, as 
the cervical canal is usually already open in 
incomplete abortion4.
In many developing countries, sharp 
curettage is still the most common method of 
treating incomplete abortion and had been the 
most commonly performed standard treatment 
since the 1930s, even though complications 
such as uterine perforation, life-threatening 
haemorrhage or post-surgical pelvic infection 
may arise. In most developed countries, 
vacuum aspiration has replaced sharp metal 
curettage, but still in many developing 
countries, physicians continue to use sharp 
metal curettage because they are not trained in 
vacuum aspiration, they do not have the 
necessary equipment to perform the procedure, 
or in some cases they are not convinced of the 
effectiveness of the procedure. Medical 
management of incomplete abortion is 
becoming increasingly common, but it may not 
be a feasible option in countries with limited 
health care resources, as it requires careful 
follow-up, continued access to medical care, 
and availability of relatively expensive drugs5. 
In the past decade, expectant care and 
medical treatment have been shown to be 
effective alternatives for treatment of 
spontaneous abortion. A number of clinical 
trials reported that expectant management 
usually achieved complete evacuation of 
product of conception (POC) within two weeks 
of diagnosis with low infection. A study has 
shown that medical management of an 
uncomplicated incomplete first trimester 
miscarriage with misoprostol, a synthetic 
prostaglandin analogue, had a 96% success 
rate and may be a suitable cost saving 
alternative.6
Unsafe miscarriage is one of the five 
leading causes of maternal mortality 
worldwide. In order to manage the treatment of 
incomplete miscarriage at hospitals, which 
often results from unsafe miscarriage, drains a 
lot of resources in healthcare systems 
throughout the developing world7. Due to the 
high level of resource consumption, reducing 
the costs associated with treating incomplete 
miscarriage would be clearly advantageous. 
Improving incomplete miscarriage services, by 
making them more accessible and cost 
effective, is a key component of improving 
family-planning services overall8. Analyzing 
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cost of treating incomplete abortion is crucial 
before the actual cost effectiveness study can 
be done. However, the study on cost analysis 
especially in hospitals with incomplete data on 
cost is very challenging.
Despite the many complications which 
may arise in using sharp curettage as the main 
mode of treatment of incomplete miscarriage, 
this is the most preferred method used by the 
Obstetrics and Gynaecology (O&G) specialists 
in UKMMC. Therefore evacuation of retained 
product of conception using sharp curettage is 
one of the most common procedures done in 
Obstetrics and Gynaecology operation theater 
in UKMMC and it consumes a lot of 
resources. Cost analysis data can enable 
policymakers and managers to identify trends 
in resource utilization and miscarriage patient 
management. Therefore this study is carried 
out to calculate the actual provider’s cost of 
treating incomplete miscarriage by sharp 
curettage.
METHODOLOGY
This is a cross-sectional study which is 
conducted at UKM Medical Centre (UKMMC) 
Cheras Kuala Lumpur starting from 1st January 
2010 to 30th March 2010. This is a 
retrospective study and partial economic 
evaluation as we only take into account the 
costs from the provider’s perspective (hospital 
cost). During this period data collection is 
done and the result is based on the average 
cost of treating incomplete abortion using 
sharp curettage per patient-day.
Universal sampling whereby patients who 
were diagnosed to have incomplete abortion 
and planned for sharp curettage from 1st 
January 2010 to 30th March 2010 were 
included into the study sample. Patient who 
has incomplete abortion and planned for sharp 
curettage but with other complications are 
excluded from the study.
Rapid assessment data collection 
technique was used to collect data on factors 
contribute to the cost of managing incomplete 
abortion. The procedures include direct 
observation at the O&G admission centre and 
in the ward, informal conversation with nurses 
and doctors involved in managing patient with 
incomplete abortion and also interview with 
key informants such as sister at gynaecology 
ward, O&G specialist, officer in charge of case 
mix system at UKMMC and officer at 
administrative department. 
Data collection was started by 
interviewing the O&G specialist to find out 
about the management protocol for patient 
with incomplete abortion. This includes their 
management procedure and staffing situation. 
Then, data on the hospital costs associated 
with management of incomplete abortion is 
collected through informal conversation with 
the officer at administrative department and 
followed by checking the data from the case 
mix system. All of the information gathered 
through the interviews and records were then 
confirmed by subsequently observing the 
complete treatment process that patients with 
incomplete abortion had to go through from 
their diagnosis to their discharge. 
Cost analysis was done using both micro-
costing as well as macro-costing. Calculation 
using macro-costing is divided into capital cost
which is further divided into building cost with 
lifespan of 20 years and 5% annualizing factor, 
furniture cost (5 years, 5% annualizing factor) 
and equipment cost (5 years, 5% annualizing 
factor) and the other cost for cost calculation is 
recurrent costs. It is calculated based on the 
human resources, drugs, consumables, utilities, 
maintenance, overhead costs and also 
laboratory investigations. Human resources, 
drugs, consumables and laboratory 
investigations are calculated based on activity-
based costing whereas consumables, utilities, 
maintenance and overhead costs are calculated 
using floor space. However, administration 
cost which is included in the overhead cost is 
calculated using apportioning, by taking the 
total cost of administration divided by the total 
number of UKMMC staff. The number is then 
multiplied by the total number of O&G staff to 
get the total administration cost for the 
department, and the total cost is divided by the 
total number of patient-day to get the 
administration cost per patient day for O&G 
patient.
The cost of human resources is calculated 
based on the number of staffs directly involved 
in each activity and the time spent with 
patients for each activity is calculated based on 
estimations of a few personnel interviewed. 
The salary per minute for each staff is 
multiplied by the time they spend with each 
patient to get the cost of human resources per 
patient.
Cost of drugs, consumables and 
laboratory investigations are calculated by 
counting the total number of items consumed 
by each patient according to the patient’s 
record then the total cost is calculated for all 
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patients. The total cost is then divided by the 
patient-day to get the total cost per patient-day.
RESULTS
Socio-demographic description
There were 46 patients diagnosed with 
incomplete abortion from January to March 
2010 in UKMMC. However, there were only 
17 records available to be analyzed since the 
other case notes are being used in the clinics 
for follow up of the patients. 
Mean age of the subjects are 31.2 years 
(min 23, max 44). Majority of subjects are 
Malays with 39 subjects (82.9%), followed by 
Chinese with 5 subjects (10.6%), India 1 
subject (2%) and other races 2 subjects (4.7%). 
The mean length of stay in the hospital for the 
obstetric and gynaecological admission is 2.5 
days. 
Cost of treatment of incomplete abortion 
with sharp curettage from provider’s 
perspective.
Universiti Kebangsaan Malaysia Medical 
Center (UKMMC) started its operation since 
1997 with building cost of RM230 million, 
spreading over 115,802 meter squared of floor 
space. For this study, the floor spaces of four 
obstetric and gynaecology (O&G) wards, the 
operation theatres and the Obstetric and 
Gynaecology Admission Centre (OGAC) are 
being used which totalled up to 3102 meter 
squared. The staff capacity for the year 2009 
for O&G department is 279 personnel, 
including 60 medical professionals, 205 
nursing staffs and 14 supporting staff. The 
total number of O&G patients is 14031 
patients, total number of incomplete abortion 
patients is 188 patients and the average length 
of stay (ALOS) for obstetric and gynaecology 
case is 2.5 days. The number of patient-days is 
calculated by multiplying the number of 
patients for the year 2009 with the ALOS, 
which totals up to 35752.5 patient-days.
The building cost per patient-day is 
RM13.83. The furniture cost is RM20.17 per 
patient day whereas the equipment cost is 
RM8.13 per patient-day. The capital cost per 
patient-day is RM42.13. Based on the above 
calculation, the capital cost involving building, 
furniture and equipment costs contribute to 
16.7% of the total treatment costs for patients 
per day admitted to UKMMC for treatment of 
incomplete abortion with sharp curettage.
The total recurrent cost to treat 
incomplete abortion with D&C is RM210.43 
(Table 1). This portion of cost is shown to be 
the higher contributory to the average cost of 
treating incomplete abortion with sharp 
curettage which contributes 83.3% of the total 
cost. Therefore it can be concluded from this 
study that the total cost of treating incomplete 
abortion using sharp curettage from the 
provider’s perspective is RM252.56 per 
patient-day (capital cost: RM42.13 + recurrent 
cost: RM210.43).
Table 1:  Recurrent costs of incomplete abortion with D&C treatment (in Ringgit Malaysia)
No. Category Cost (RM)
1. Human Resources 108.12
2. Drugs 0.77
3. Consumables 0.66
4. Utilities 13.83
5. Maintenance 40.69
6. Overhead 42.79
7. Laboratory Investigations 3.57
TOTAL 210.43
DISCUSSION
Based on this study, the average direct 
cost from the perspective of UKMMC as the 
provider for the treatment of incomplete 
miscarriage using sharp curettage per patient 
day is RM252.56. If the total cost per episode 
is taken into account by multiplying it with the 
average length of stay therefore the total cost 
per episode is RM631.40. This value is still 
lower than the studies done overseas, however, 
this study has a number of limitations in which 
there is not enough data especially with 
regards to the individual equipment being used 
in the operation theatre, the sample size is also 
quite small as the medical records are difficult 
to obtain as they are being used in other 
departments or kept in the specialist clinic for 
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follow up. Although this value is far from the 
value from cost per DRG (Diagnosis-Related 
Group) from the Case-Mix Unit which totals 
up to RM20139. This is also in comparison 
with study done by Hughes et al. where they 
found that the average cost of surgical 
treatment was GBP397 versus medical 
treatment (GBP347) 10, and a cost analysis 
study based on modeling found that surgical 
evacuation will cost US$2007 per patient 
compared to misoprostol group (USD$1000) 
and expectant (USD$1172)11.
Most of the costs were contributed by the 
recurrent costs, with the overhead cost covers 
about 51.6% of the total recurrent cost, and 
approximately 43% of the total cost. The 
highest cost is related to the administration 
cost, which was calculated based on the total 
cost of O&G department averaged per patient-
day. This study, however, did not look into 
other costs for example the patient’s cost and 
the effectiveness of the method, therefore, no 
reference can be made with regards to this.
Despite being at a higher cost compared 
to medical abortion, surgical procedure is still 
being done and is a preferred method 
especially when there is clinical evidence that 
the miscarriage is incomplete12. Other study 
showed that surgical procedure is a faster, 
safer and more acceptable up to about 18 
weeks of gestation13 compared to primary 
prostaglandins (PG) and PGF2α, and there is no 
difference in the long term conception rate and
pregnancy outcome compared to medical 
treatment14, and there is no difference existed 
in activities of daily living on any of the eight 
subscales of the UK SF-3615.
CONCLUSION
Based on the cost analysis on the 
treatment of incomplete abortion using sharp 
curettage that has been performed in 
UKMMC, the average cost from the provider’s 
perspective is RM252.56. Because the 
treatment is quick and safe in comparison to 
medical and expectant approach, the patients 
can return to their daily activities faster and 
since there is no difference in the short term 
outcome such as the scores in SF-36 as well as 
long term outcome in terms of reproductive 
rates and pregnancy rates, it might be a cost-
effective method if taken from the societal 
point of view. Therefore, a more 
comprehensive cost-analysis study involving a 
full economic evaluation especially in the costs 
from the provider’s perspective as well as the 
patients’ cost including the quality of life and 
reproductive potential is highly recommended.
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